Search | Chemistry World

DuPont and Monsanto settle Roundup dispute

12 April 2013 Business

Firms drop expensive ongoing litigation in favour of a licensing deal

Interpol teams up with pharma

18 March 2013 Business

Pharmaceutical crime programme will seek to reduce trade in fake drugs

Dow makes $1.5bn divestiture plans

15 March 2013 Business

Liveris in favour of 'selectively pruning' further non-core units

Dispute over Arkema finances

13 March 2013 Business

French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year

Alcohol dependence pill approved in EU

5 March 2013 Business

Selincro tablets from Lundbeck designed to reduce consumption of alcohol

University to acquire Shell UK R&D site

5 March 2013 Business

Site at Thornton will become a science park under the stewardship of the University of Chester

Dow rapped for $1bn tax scheme

1 March 2013 Business

Judge opines: 'tax law deals in economic realities, not legal abstractions'

Does chemical regulation boost innovation?

28 February 2013 Business

Report suggests that supply of innovation responds to extra demand created by new laws

Talk of a $6.6bn deal for Elan

27 February 2013 Business

Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights

$595m octreotide deal grabs Roche

21 February 2013 Business

Company will get worldwide rights to oral formulation of growth hormone drug

Merck resolves Vytorin case for $688m

19 February 2013 Business

Investors say the company knew about Enhance trial failure but withheld information

BMS sells OTC drugs for $482m

14 February 2013 Business

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser

Ozone device for food packaging

12 February 2013 Business

Device uses plasma to create ozone inside sealed packaging

Biogen buys Tysabri from Elan for $3.25bn

8 February 2013 Business

Elan earns huge cash injection for blockbuster drug

BASF drops GM potato projects

7 February 2013 Business

Move follows transfer of R&D from Europe to US

Reach reviewed: no change required

6 February 2013 Business

But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says

Zoetis IPO launches at $2.2bn

1 February 2013 Business

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh

DCD in New Zealand milk

31 January 2013 Business

Dicyandiamide poses no food risk but fertiliser companies have suspended sales

Sabic invests $500m in new R&D centres

30 January 2013 Business

Four centres to be created: two in Saudi Arabia, one in India and one in China

Allergan buys MAP for $958m

25 January 2013 Business

Deal strengthens Allergan's position in neurology with Levadex for treating migraine

OM Group to exit cobalt business

24 January 2013 Business

Deal worth up to $435 million includes downstream activities, in particular cobalt refining in Kokkola, Finland

Vasella to leave Novartis in August

24 January 2013 Business

Long serving chair of the board of directors will be succeeded by Jörg Reinhardt

Flu vaccine without the eggs approved

22 January 2013 Business

Flublok does not require flu virus or eggs for manufacture

BASF ups Pronova bid

16 January 2013 Business

Pronova BioPharma specialises in omega-3 fatty acids

UK companies struggling with Reach

16 January 2013 Business

Regulation is 'elephant in the room' as manufacturers fail to recognise implications

Laropiprant recalled

14 January 2013 Business

Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol

Pharma industry 'strategic crisis'

11 January 2013 Business

The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says

Dow Corning to reduce roster by 500

10 January 2013 Business

Company says it must respond to oversupplied markets, high raw materials costs and poor growth in many regions

EPA focuses on five chemicals

9 January 2013 Business

Risk assessments for five chemicals put out for public consultation

Illumina investment push

8 January 2013 Business

$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests

Wellcome Trust launches investment wing

7 January 2013 Business

Trust provides £200 million to create Syncona, which will support innovative healthcare businesses

TB drug milestone for bedaquiline

3 January 2013 Business

First TB drug with a new mechanism of action for 40 years wins approval

Clariant sells business bundle for CHF500m

3 January 2013 Business

Textile, paper and emulsion businesses to go to US investment firm

AkzoNobel sells $1bn chunk of paints business

20 December 2012 Business

North American decorative paints business was responsible for 7% of total AkzoNobel sales in 2011, amounting to $1.5 billion

Gilead buys YM for $510m

20 December 2012 Business

Deal gives Gilead access to Janus kinase inhibitor CYT387 for the treatment of myelofibrosis

BP shifting ethanol focus to Brazil

12 December 2012 Business

Company to invest $350 million to expand production from sugarcane in Brazil

Pfizer's lost gold

10 December 2012 Business

A stash of gold dust bought for $700,000 last year has gone missing from a Pfizer lab in St Louis, Missouri, US

EU companies increasing R&D

10 December 2012 Business

Difficult economic climate has not diminished EU enthusiasm for R&D

Mango and Zara sign up to 'detox' plan

7 December 2012 Business

Greenpeace campaign to remove hazardous chemicals from the clothing industry is garnering big name support

Return on drug R&D dropping

6 December 2012 Business

The pharma industry is getting less and less return on investment in R&D but trend seems to be bottoming out

Baxter to pay $4bn for dialysis firm

6 December 2012 Business

Gambro makes products for hemodialysis and continuous renal replacement therapy

Drug R&D costs rising

4 December 2012 Business

Review from UK consultancy suggests ten-fold increase in per medicine R&D costs over last 30 years

Lignin to lead bio-based chemicals?

28 November 2012 Business

Report says bio-polymer could become a commercial opportunity within three years

GSK expands in India and Nigeria

28 November 2012 Business

Company has struck deals to increase ownership of subsidiaries

Roche and the Tamiflu data

27 November 2012 Business

Company position on access to data for antiviral Tamiflu (oseltamivir) tablets could be softening

Solvay launches €300,000 chemistry prize

26 November 2012 Business

To recognise science that could 'shape tomorrow's chemistry and help human progress’

Schiff seals deal with Reckitt

23 November 2012 Business

Boards approves $1.4 billion Reckitt offer as Bayer pulls out of running

Record insider trading case hits pharma

23 November 2012 Business

US authorities claim that hedge fund manager made illicit gains of $276 million in response to confidential clinical trial data

BASF bids €664m for omega-3 company

22 November 2012 Business

Pronova BioPharma makes pharmaceutical ingredients as well as nutritional supplements based in omega-3 fatty acids

Reckitt steps into Schiff deal

19 November 2012 Business

Higher bid could sink Bayer's $1.2bn attempt to buy vitamins and nutritional supplements company

BP to pay £4.5 billion for disaster

19 November 2012 Business

Company will plead guilty to criminal charges including felony manslaughter

What lies within

16 November 2012 Business

Bayer boss Marijn Dekkers aims to increase impact of good R&D across different internal units

DSM buys food ingredients firm

8 November 2012 Business

$634 million deal for Fortitech will expand 'value chain presence'

Takeda buys Envoy for $140m

7 November 2012 Business

The small US biotech will boost Takeda's drug discovery efforts

Approval for first gene therapy drug

5 November 2012 Business

Glybera (alipogene tiparvovec) injections have been approved in Europe

Panel delivers final PFOA report

2 November 2012 Business

Probable link between perfluorooctanoic acid, used by DuPont to make fluoro-polymers, and high cholesterol

Novartis biotech plant for Singapore

1 November 2012 Business

Firm will invest $500 million in biotech manafacturing

Bayer spends $1.2bn on supplement maker

31 October 2012 Business

Schiff nutrition will strengthen Bayer in the US

More jobs go: Lonza cuts 500

31 October 2012 Business

A bid to ‘secure the future’ of the site at Visp in Switzerland

Chemists contribute to prior art hunt

31 October 2012 Business

A crowdsourcing website that pays for prior art is gaining popularity – can chemists make money?

BP drops $300m US ethanol plans

29 October 2012 Business

Company to focus on R&D and licensing existing technology

Patent woes lead to sharp sales losses

26 October 2012 Business

Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs

Chemical giants cut 4000 jobs

24 October 2012 Business

DuPont and Dow launch restructuring programmes as sales fall Q3

Bankruptcy for US Li ion battery maker

23 October 2012 Business

Johnson Controls to buy the automotive business of A123 Systems for $125 million

Pfizer to pay $700m for Ritalin re-formulated

22 October 2012 Business

Pfizer to buy a company with a liquid formulation of historic ADHD drug methylphenidate

€2.5bn written off AkzoNobel paint business

19 October 2012 Business

Company records loss on back of impairment

$2.2bn speciality chemicals acquisition

18 October 2012 Business

Family-owned US speciality chemical company Champion Technologies is to be bought by Ecolab

Carbon dioxide to chemical partnership

17 October 2012 Business

Petronas to partner with gas fermentation specialist LanzaTech

Merck & Co $460m ion channel deal

2 October 2012 Business

Deal with Ablynx relates to antibody fragments

Pharma should 'double output by 2022'

1 October 2012 News and Analysis

US report says pharma industry must set itself an ambitious target for drug development

Regorafenib approved in US

28 September 2012 Business

Stivarga tablets approved for treatment of advanced colorectal cancer

Solvay rare earth recycling in France

28 September 2012 Business

€15 million investment in two new sites to diversify supply

Boehringer drops virology R&D

26 September 2012 Business

R&D site in Laval, Canada, to close with loss of 170 jobs

Sanofi to cut 900 jobs in France

26 September 2012 Business

Number of jobs to be cut reduced from 2500 to 900 following outcry

Measuring nano the European way

25 September 2012 Business

Report concludes that companies will need lots of methods to define nanomaterials

$100m of diabetes R&D in China

24 September 2012 Business

Novo Nordisk will create 130–200 new research jobs

Pineapple gel approved for burns

24 September 2012 Business

EU regulators approve NexoBrid gel from MediWound for removal of scab tissue

BASF buys Becker Underwood for $1bn

21 September 2012 Business

Deal covers 10 production site for agrochemicals

Bayer $145 million animal health deal

18 September 2012 Business

Move will strengthen anti-infective portfolio and introduce reproductive hormones

Drug discovery becomes Facebook game

17 September 2012 Business

Boehringer Ingelheim offers a first look at the beta version of Syrum

Solvay adds fluorinated capacity

12 September 2012 Business

Company will double capacity at plant in Salindres, France, which makes triflic acid

BASF backs automotive growth

11 September 2012 Business

While other chemical companies are trying to reduce their exposure to the automotive industry, BASF is heading in the other direction

Merck KGaA to cut 1100 German jobs

6 September 2012 Business

Company provides detail of restructuring programme announced in February

Valeant buys $2.6bn skincare firm

6 September 2012 Business

Medicis will strengthen the dermatology portfolio

DuPont sells car paints for $5bn

4 September 2012 Business

US investment group picks up 11,000 employees and $4 billion in annual sales

Artists form anti-fracking group

4 September 2012 Business

New York decision on fracking expected soon

Kevlar equivalent banned for 20 years

4 September 2012 Business

US rules in favour of DuPont in Kevlar trade secrets case

Myelofibrosis drug approved in EU

28 August 2012 Business

Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow

Rockwood to pay C$720m for lithium firm

28 August 2012 Business

The chemical group has struck a deal to buy Talison, an Australian lithium producer with headquarters in Perth.

Crowdsourcing science site to launch

28 August 2012 Business

Marblar aims to find uses for neglected patents by 'gamifying' the technology transfer process

Alzheimer's drug flops in Phase III

24 August 2012 Business

Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials

Merck KGaA buys cell culture company

24 August 2012 Business

Biochrom makes cell culture media and buffer solutions

Flight fuelled by plastic waste

23 August 2012 Business

Liquid fuel made entirely from plastic waste will power a single engine plane from from London to Sydney

Generic Actos approved

20 August 2012 Business

Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets

BASF parts with paints

17 August 2012 Business

German and French parts of subsidiary Relius sold to wholesaler Prosol

Pfizer to pay $250m for Nexium

17 August 2012 Business

AstraZeneca has sold rights to an over the counter version of its heartburn tablets

DSM to cut 1000 jobs

14 August 2012 Business

Netherlands speciality chemical company will reduce its headcount by 1000 over the next 18 months

Elan spins off drug discovery

14 August 2012 Business

The new company will be called Neotope Biosciences and focus on chronic degenerative diseases

DSM buys into cattle supplements

13 August 2012 Business

The company has struck a EUR465 million deal to acquire Tortuga

Pfizer secures Sandwich buyer

3 August 2012 Business

The R&D site in Sandwich, UK, has been bought by a private consortium

Search Results

Selected Filters

Filter Results